BHVN - Biohaven Pharmaceutical Holding Co Ltd. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - BHVN (1689813)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
49 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m
P6+4+0+0+0

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2018-12-03
BHVNDoogan DeclanDirS - Sale$41.95-40,0001,619,915-2%-$1,678,000
AM
2018-06-11
BHVNBerman RobertChief Medical OfficerS - Sale$36.36-76,692244,000-24%-$2,788,707
D
2018-06-15
BHVNGentile KimberlyVP of OperationsS - Sale+OE$40.02-12,5000-100%-$500,250
M
2018-06-08
BHVNBerman RobertChief Medical OfficerS - Sale$36.33-104,155784,601-12%-$3,784,303
M
2018-06-05
BHVNBerman RobertChief Medical OfficerS - Sale$36.01-25,845898,205-3%-$930,714
M
2018-06-04
BHVNDoogan DeclanDirS - Sale$35.25-89,2161,659,915-5%-$3,145,112
M
2018-05-30
BHVNDoogan DeclanDirS - Sale$35.03-110,7841,749,131-6%-$3,881,056
M
2018-05-30
BHVNCoric VladCEOS - Sale$35.02-50,0001,050,000-5%-$1,750,900
D
2018-05-30
BHVNEngelhart JamesCFOS - Sale+OE$35.00-5,0000-100%-$175,000
2018-05-10
BHVNBerman RobertChief Medical OfficerS - Sale$26.82-35,000924,050-4%-$938,706
2018-05-07
BHVNEngelhart JamesCFOS - Sale$27.67-2,5000-100%-$69,175
2018-04-10
BHVNBerman RobertChief Medical OfficerS - Sale$24.66-35,000959,050-4%-$863,132
2018-03-12
BHVNBerman RobertChief Medical OfficerS - Sale$30.11-35,000994,050-3%-$1,053,929
D
2018-03-01
BHVNGentile KimberlyVP of OperationsS - Sale+OE$32.87-5,0000-100%-$164,344
2018-02-21
BHVNEngelhart JamesCFOS - Sale$29.60-5383,038-15%-$15,925
D
2018-02-01
BHVNGentile KimberlyVP of OperationsS - Sale+OE$32.78-5,0000-100%-$163,900
2018-01-31
BHVNBailey GregoryDirS - Sale$33.71-50,0002,475,101-2%-$1,685,352
2018-01-23
BHVNBailey GregoryDirS - Sale$32.79-16,0002,525,101-1%-$524,640
AM
2018-01-19
BHVNPortage Biotech Inc.former 10% ownerS - Sale$31.31-59,39654,494-52%-$1,859,406
EM
2018-01-19
BHVNPortage Biotech Inc.former 10% ownerS - Sale$23.34-59,39654,494-52%-$1,386,312
D
2018-01-22
BHVNEngelhart JamesCFOS - Sale+OE$32.50-10,0003,576-74%-$325,000
M
2018-01-19
BHVNBailey GregoryDirS - Sale$30.76-49,0002,541,101-2%-$1,507,459
M
2018-01-16
BHVNDoogan DeclanDirS - Sale$26.95-128,0581,859,915-6%-$3,451,297
2018-01-16
BHVNBailey GregoryDirS - Sale$26.52-40,0002,590,101-2%-$1,060,800
M
2018-01-10
BHVNDoogan DeclanDirS - Sale$26.78-121,9421,178,058-9%-$3,265,537
2018-01-10
BHVNBerman RobertChief Medical OfficerS - Sale$27.52-35,0001,070,050-3%-$963,133
A
2018-01-04
BHVNPortage Biotech Inc.10%S - Sale$28.62-4,3506,301,5000%-$124,504
M
2018-01-05
BHVNPortage Biotech Inc.10%S - Sale$30.06-84,8816,216,619-1%-$2,551,573
M
2018-01-03
BHVNBailey GregoryDirS - Sale$28.71-50,0001,170,299-4%-$1,435,528
2018-01-04
BHVNPortage Biotech Inc.10%S - Sale$28.62-4,350124,371-3%-$124,504
2018-01-03
BHVNPortage Biotech Inc.10%S - Sale$28.61-35,6506,305,850-1%-$1,020,071
D
2018-01-02
BHVNGentile KimberlyVP of OperationsS - Sale+OE$27.60-5,0000-100%-$138,000
2017-12-20
BHVNBailey GregoryDirS - Sale$26.31-39,4301,220,299-3%-$1,037,290
2017-12-19
BHVNBerman RobertChief Medical OfficerS - Sale$24.10-10,0001,105,050-1%-$241,000
2017-12-11
BHVNBerman RobertChief Medical OfficerS - Sale$21.28-25,0001,115,050-2%-$532,000
D
2017-12-01
BHVNGentile KimberlyVP of OperationsS - Sale+OE$21.99-5,0000-100%-$109,962
M
2017-11-29
BHVNBailey GregoryDirS - Sale$25.48-9,9701,259,729-1%-$254,005
M
2017-11-24
BHVNBailey GregoryDirS - Sale$25.92-20,6001,269,699-2%-$534,012
DM
2017-11-09
BHVNEngelhart JamesCFOS - Sale+OE$26.58-30,5383,576-90%-$811,561
M
2017-11-09
BHVNBerman RobertChief Medical OfficerS - Sale$25.76-160,0001,140,050-12%-$4,122,064
D
2017-11-01
BHVNGentile KimberlyVP of OperationsS - Sale+OE$29.28-5,0000-100%-$146,385
D
2017-11-01
BHVNTilton JohnChief Commercial OfficerS - Sale+OE$29.25-30,0001,614-95%-$877,586
M
2017-10-31
BHVNCoric VladCEOS - Sale$29.41-150,000575,000-21%-$4,411,835
2017-05-09
BHVNEngelhart JamesCFOP - Purchase$17.00+2,5003,576+232%+$42,500-1
2017-05-09
BHVNConway CharlesChief Scientific OfficerP - Purchase$17.00+4,0004,000New+$68,000-1
2017-05-09
BHVNBerman RobertChief Medical OfficerP - Purchase$17.00+501,300,0500%+$850-1
D
2017-05-09
BHVNChilds John WDir, 10%P - Purchase$17.00+415,0002,719,438+18%+$7,055,000+10
D
2017-05-09
BHVNCha AlbertDirP - Purchase$17.00+470,0001,976,818+31%+$7,990,000+10
D
2017-05-09
BHVNBailey GregoryDirP - Purchase$17.00+175,0001,290,299+16%+$2,975,000+10
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top